Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open-label, Genotype-match Controlled, Multicenter Clinical Trial to Investigate the Efficacy and Safety of Intra-amniotic ER004 as a Prenatal Treatment for Male Subjects With XLHED

NCT04980638 is registered in ClinicalTrials.gov with EspeRare Foundation as lead sponsor.

NCT NCT04980638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04980638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open-label, Genotype-match Controlled, Multicenter Clinical Trial to Investigate the Efficacy and Safety of Intra-amniotic ER004 as a Prenatal Treatment for Male Subjects With XLHED
Lead sponsor
EspeRare Foundation
Phase
Phase 2
Overall status
Recruiting
Start date
April 26, 2022
Completion date
December 31, 2032
Enrollment
20 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

x-linked hypohidrotic ectodermal dysplasia (xlhed)